Clinical Trials Directory

Trials / Unknown

UnknownNCT04867512

Botanical Blend on the Gut Microbiome and Gut-Skin-Axis in Small Intestinal Bacterial Overgrowth (SIBO)

The Effects of a Botanical Blend on the Gut Microbiome and Gut-Skin-Axis in Small Intestinal Bacterial Overgrowth (SIBO)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
35 (estimated)
Sponsor
Integrative Skin Science and Research · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess how an oral botanical blend alters the gut microbiome and the skin biophysical properties in people with SIBO.

Detailed description

Certain oral botanical blends have many antimicrobial properties. This study will evaluate if a botanical blend can improve the gut and skin health of people with small intestinal bacterial overgrowth (SIBO) since it is caused by an overgrowth of bacteria in the small intestine.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLiquid TinctureBiocidin Liquid Tincture: 1 drop by mouth twice daily, increased by one drop each day until 15 drops twice daily have been reached. 15 drops by mouth twice daily will be maintained through the duration of the study.
DIETARY_SUPPLEMENTGI DetoxGI Detox: 2 capsules by mouth every evening and 1 hour away from all food maintained through the duration of the study.
DIETARY_SUPPLEMENTOlivirexOlivirex: 2 capsules by mouth twice daily taken with Biocidin liquid tincture starting at week 10 until week 14 of the study for non-responders determined by symptoms and lactulose breath test results.

Timeline

Start date
2021-04-27
Primary completion
2021-04-30
Completion
2022-02-01
First posted
2021-04-30
Last updated
2021-05-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04867512. Inclusion in this directory is not an endorsement.